References
Jemec GB, Kimball AB. Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol 2015; 73: S4–7.
Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol 2017; 77: 118–22.
Schrader AM, Deckers IE, van der Zee HH, Boer J, Prens EP. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity. J Am Acad Dermatol 2014; 71: 460–7.
Canoui-Poitrine F, Revuz JE, Wolkenstein P, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol 2009; 61: 51–7.
Fabbrocini G, Marasca C, Megna M, Peris K; HS Quality of Life Study Group. Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol 2019; 33: 25–7.
Matusiak Ł. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol 2018. doi: https://doi.org/10.1111/bjd.16603.
Patel KR, Rastogi S, Singam V, Lee HH, Amin AZ, Silverberg JI. Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample. Br J Dermatol 2019; 181: 275–81.
Machado MO, Stergiopoulos V, Maes M, et al. Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol 2019. doi: https://doi.org/10.1001/jamadermatol.2019.0759.
Zouboulis CC, Tzellos T, Kyrgidis A, et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401–9.
Sampogna F, Mastroeni S, Pallotta S, et al. General health status in psoriasis patients, as assessed by the SF-12, is poorly associated with PASI. J Eur Acad Dermatol Venereol 2019; 33: e233–5.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
Funding: This work was supported, in part, by the “Progetto Ricerca Corrente 2018 and 2019” of the Italian Ministry of Health, Rome, Italy. Conflicts of interest: FS acted as a consultant for Abbvie, Eli Lilly, Janssen, Pierre Fabre, not related to the present study.
About this article
Cite this article
Napolitano, M., Mastroeni, S., Fusari, R. et al. The International Hidradenitis Suppurativa Severity Score System (IHS4) is a valuable tool to assess sex-associated differences. Eur J Dermatol 30, 201–203 (2020). https://doi.org/10.1684/ejd.2020.3743
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2020.3743